当前位置:首页 - 行情中心 - 仟源医药(300254) - 财务分析 - 现金流量表

仟源医药

(300254)

  

流通市值:19.71亿  总市值:22.30亿
流通股本:2.27亿   总股本:2.57亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金421,004,540.07212,465,637.45791,404,089567,545,035.96
  收到的税费返还--1,086,813.441,086,813.44
  收到其他与经营活动有关的现金14,354,703.479,795,250.0341,340,136.9617,271,486.54
  经营活动现金流入小计435,359,243.54222,260,887.48833,831,039.4585,903,335.94
  购买商品、接受劳务支付的现金84,099,022.8755,488,886.34152,789,255.1269,952,004.49
  支付给职工以及为职工支付的现金99,229,244.7856,319,385.28179,902,706.01129,851,459.88
  支付的各项税费52,563,970.9726,557,575.53126,371,971.2392,437,962.28
  支付其他与经营活动有关的现金118,392,945.462,791,612.4277,999,234.81218,250,055.43
  经营活动现金流出小计354,285,184.02201,157,459.55737,063,167.17510,491,482.08
  经营活动产生的现金流量净额81,074,059.5221,103,427.9396,767,872.2375,411,853.86
二、投资活动产生的现金流量:
  取得投资收益收到的现金1,239,126.431,239,126.432,360,334.01-
  处置固定资产、无形资产和其他长期资产收回的现金净额212,311.8576,328352,679121,979
  投资活动现金流入小计1,451,438.231,815,454.432,713,013.01121,979
  购建固定资产、无形资产和其他长期资产支付的现金13,316,641.348,055,327.5434,315,048.8428,643,263.66
  投资支付的现金-147,410,43860,289,231.0460,289,231.04
  支付其他与投资活动有关的现金13,524,385.56---
  投资活动现金流出小计26,841,026.9155,465,765.5494,604,279.8888,932,494.7
  投资活动产生的现金流量净额-25,389,588.67-153,650,311.11-91,891,266.87-88,810,515.7
三、筹资活动产生的现金流量:
  吸收投资收到的现金17,520,000-43,960,00043,960,000
  其中:子公司吸收少数股东投资收到的现金10,800,000---
  取得借款收到的现金134,500,000112,500,000238,300,000150,800,000
  收到其他与筹资活动有关的现金65,000,00065,000,00049,000,00048,000,000
  筹资活动现金流入小计217,020,000177,500,000331,260,000242,760,000
  偿还债务支付的现金64,809,470.1353,009,470.13285,640,529.87223,600,000
  分配股利、利润或偿付利息支付的现金28,805,931.14,126,152.5418,967,833.4415,152,157.79
  其中:子公司支付给少数股东的股利、利润20,000,000---
  支付其他与筹资活动有关的现金243,634,531.9111,527,447.7319,723,458.3311,151,388.45
  筹资活动现金流出小计337,249,933.1468,663,070.4324,331,821.64249,903,546.24
  筹资活动产生的现金流量净额-120,229,933.14108,836,929.66,928,178.36-7,143,546.24
五、现金及现金等价物净增加额-64,545,462.29-23,709,953.5811,804,783.72-20,542,208.08
  加:期初现金及现金等价物余额161,311,824.68161,311,824.68149,507,040.96149,507,040.96
  期末现金及现金等价物余额96,766,362.39137,601,871.1161,311,824.68128,964,832.88
补充资料:
  净利润11,718,213.71-56,437,313.63-
  资产减值准备747,362.6-8,035,871.74-
  固定资产和投资性房地产折旧18,135,406.49-34,550,985.97-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧18,135,406.49-34,550,985.97-
  无形资产摊销9,365,946.82-17,405,407.76-
  长期待摊费用摊销1,910,203.34-1,994,161.32-
  处置固定资产、无形资产和其他长期资产的损失---8,941,963.33-
  固定资产报废损失413,925.54-428,698.9-
  公允价值变动损失--18,934,476-
  财务费用11,810,014.15-23,082,774.12-
  投资损失2,974,955.81--3,971,475.89-
  递延所得税-2,679,828.26--3,120,815.62-
  其中:递延所得税资产减少673,453.02--1,612,555.62-
    递延所得税负债增加-3,353,281.28--1,508,260-
  存货的减少-41,658,445.23--2,296,496.87-
  经营性应收项目的减少52,677,303.58--40,668,684.56-
  经营性应付项目的增加-6,607,978.52--36,673,520.08-
  其他18,589,674.12-24,166,202.38-
  不涉及现金收支的投资和筹资活动金额其他项目--0-
  现金的期末余额96,766,362.39-161,311,824.68-
  减:现金的期初余额161,311,824.68-149,507,040.96-
  现金及现金等价物的净增加额-64,545,462.29-11,804,783.72-
公告日期2026-08-252026-04-282026-04-282025-10-30
审计意见(境内)标准无保留意见
TOP↑